The information displayed in the AIM should not be reported as representing the official views of the OECD or of its member countries.
OpenAI, alongside Founders Fund and Lux Capital, has invested $30 million in New York-based startup Valthos. Valthos is developing AI-powered software to detect and counter potential AI-engineered biological threats, aiming to prevent future bioweapon attacks enabled by advances in artificial intelligence. No actual incident has occurred yet.[AI generated]






































